Cancer Patients Europe had the pleasure of hosting the first event on Patient Leadership to tackle Cancer in Europe and presenting CPE's mission to… Read More
The first face-to-face OPMDay is on August 30th-31st in Antwerp, Belgium. The 2023 meeting focuses on the clinical and pathological diagnosis, biomarker and biological… Read More
From Europe's Beating Cancer Plan to the new HTA Regulation: our CEO Antonella Cardone discusses Cancer Patients Europe's mission and policy priorities answering questions… Read More
The my Cancer my Concern initiative has highlighted the gap in genomic testing awareness. Cancer Patients Europe and Exact Sciences discuss it with pharmaphorum.com Read… Read More
Does a mammogram hurt? Will a biopsy scar be noticeable? How often should I get a breast cancer screening? The EU-funded project ThermoBreast is… Read More
On 6 June, Cancer Patients Europe joined together with 31 other health stakeholders to share views on specific recommendations for a potential opt-out mechanism… Read More
On 28 February 2023, Pancreatic Cancer Europe (PCE) and Cancer Patients Europe (CPE) held a webinar to exchange views on how best to enhance cooperation on the HTA process… Read More
Find here infographics of the topline country results (in English) about the myCancer myConcern initiative. Feel free to email us requesting the documents in… Read More
Recent years have seen growing recognition of the role that data can play in enabling not only better health system performance, but also better… Read More
Join our CEO Antonella Cardone at the expert roundtable hosted by MEP Stelios Kympouropoulos at the European Parliament and discuss how real-world data can… Read More
In the 2022 State of the European Union address, European Commission President von den Leyen announced a new European Mental Health Strategy. As a… Read More
In order to support the development or strengthening the cooperation among all relevant stakeholders and better understand the role that patients can play in the process… Read More
On the 17th of November 2022, CPE launched the results of the first European-wide patient survey in genomic testing in breast cancer. 4 out… Read More